Time Source Company Announcement
14 Mar 2022 07:15 AM Transaction in Own Shares
14 Mar 2022 07:15 AM Advanced Oncotherapy (AVO) - LIGHT: regulatory ...
14 Mar 2022 07:05 AM
Fourth Quarter 2021 Euro and GBP Equivalent Div...
14 Mar 2022 07:05 AM Lynparza approved in US for early breast cancer
14 Mar 2022 07:05 AM Directorate Change
14 Mar 2022 07:05 AM Visible Gold Identified at HR3. Progress of Dri...
14 Mar 2022 07:03 AM Transaction in Own Shares
14 Mar 2022 07:02 AM Chief Financial Officer Board Appointment Date
14 Mar 2022 07:01 AM Monthly Investor Report
14 Mar 2022 07:00 AM Director/PDMR Shareholding
14 Mar 2022 07:00 AM Epwin Group (EPWN): The best is yet to come
14 Mar 2022 07:00 AM Faron Publishes Research From INTEREST Trial
14 Mar 2022 07:00 AM Humanitarian Fund Expanded to US$7.5 Million
14 Mar 2022 07:00 AM Holding(s) in Company
14 Mar 2022 07:00 AM Directorate Change
14 Mar 2022 07:00 AM Holding(s) in Company
14 Mar 2022 07:00 AM Appointment of CFO
14 Mar 2022 07:00 AM Block Listing Six Monthly Return
14 Mar 2022 07:00 AM Directorate Changes
14 Mar 2022 07:00 AM Directorate Change
14 Mar 2022 07:00 AM Appointment of Trine Borum Bojsen as a NED
14 Mar 2022 07:00 AM Launch of outdoor marketing campaign
14 Mar 2022 07:00 AM Launch of Sanctions Compliance Solution
14 Mar 2022 07:00 AM Director/PDMR Shareholding
14 Mar 2022 07:00 AM Holding(s) in Company
14 Mar 2022 07:00 AM Holding(s) in Company
14 Mar 2022 07:00 AM Management Changes and Trading Update
14 Mar 2022 07:00 AM Branch Register: Dividend Finalisation Information
14 Mar 2022 07:00 AM Update on Board changes
14 Mar 2022 07:00 AM Investor Presentation
14 Mar 2022 07:00 AM Director Appointment
14 Mar 2022 07:00 AM Monthly Factsheet
14 Mar 2022 07:00 AM BLOCK LISTING SIX MONTHLY RETURN
14 Mar 2022 07:00 AM Opening of New Dartford Depot
14 Mar 2022 07:00 AM Appointment of Joint Corporate Broker
14 Mar 2022 07:00 AM Edison review on Premier Miton Global Renewables
14 Mar 2022 07:00 AM Investor Presentation - 31st March
14 Mar 2022 07:00 AM Transaction in Own Shares
14 Mar 2022 07:00 AM Firm commitments for A$8.8 million placement
14 Mar 2022 07:00 AM Acquisition Completion of Triad Life Sciences Inc
14 Mar 2022 07:00 AM All-cash proposal to acquire Turquoise Hill
14 Mar 2022 07:00 AM 2021 Annual Financial Report
14 Mar 2022 07:00 AM Preliminary Results for year ended 2 January 2022
14 Mar 2022 07:00 AM Update on US review of Fasenra in nasal polyps
14 Mar 2022 07:00 AM Phase 1 First Gas
14 Mar 2022 07:00 AM FURTHER OPERATIONAL UPDATE REGARDING RCE-2 WELL
14 Mar 2022 07:00 AM Interim Financial Report
14 Mar 2022 07:00 AM Fleet Swap Agreement with Core Scientific
14 Mar 2022 07:00 AM Full year results for year ended 31 December 2021
14 Mar 2022 07:00 AM Investor Presentation
UK 100

Latest directors dealings